Irrational medicine use and poor pharmaceutical management are widespread problems throughout all levels of Sierra Leone’s health system. Misuse, underuse, and overuse of medicines are particularly worrying because they contribute to the rise of antimicrobial resistance (AMR) and threaten the effective prevention and treatment of infections caused by bacteria, parasites, and viruses. Recognizing that coordinated […]
As part of World Antibiotic Awareness Week 2017, we present a Q&A with Mohan P. Joshi, MBBS, MSc, MD, SIAPS principal technical advisor. Dr. Joshi is responsible for providing technical guidance and support in the planning and implementation of rational medicine use and antimicrobial resistance (AMR)-related activities. Are there new AMR threats that are particularly worrying? […]
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS, at USAID in Arlington, VA on November 9 2017.
Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats —one that could erode gains against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. While AMR has emerged as a critical issue at the global level, current efforts to address AMR are insufficient to curb its spread. Immediate, cross-cutting, and multidisciplinary action is required to adequately address the multidimensional drivers of AMR. In the health sector, strengthening the systems through which health services and medicines are provided is a prerequisite to making progress against AMR. This technical brief discusses how SIAPS is working to address AMR through a health system strengthening approach with interventions spanning the global, regional, national, and local levels.
This inventory is a selected list of resources and interventions that support antimicrobial resistance (AMR) containment. The objective of this inventory is to provide a list of key resources, tools, and interventions that create or strengthen systems that are necessary to improve antimicrobial use and AMR containment. Along with the full references, links are provided directly to the documents or to sites from where the documents can be downloaded. The intention is to periodically update the inventory as new resources, tools, and evidence-based interventions become available.
Antimicrobial resistance (AMR) is one of the world’s most pressing global health threats and could erode the progress made in the treatment of HIV/AIDS, tuberculosis, malaria, and many other infectious diseases. Although AMR occurs naturally, many interrelated factors, including excessive or inappropriate use of antibiotics, poor control practices, and infection prevention, contribute to its acceleration […]
Antimicrobial resistance (AMR) occurs when microorganisms develop a resistance to a medicine that was originally intended to disable or kill them. While microbes naturally develop resistance to antimicrobials over time, AMR is accelerated by the overuse and misuse of antimicrobial medicines and non-adherence to treatment regimens. AMR jeopardizes the effectiveness of complex surgeries and procedures […]
This guide aims to help individuals, organizations, and governments develop, establish, and maintain effective multidisciplinary and multisectoral coalitions to combat AMR. This document provides guidance on building and strengthening coalitions to combat AMR through five key elements. It primarily focuses on the creation and establishment of new coalitions; however, these elements are relevant throughout the lifespan of a coalition, and revisiting each periodically may be important as coalitions grow and evolve, expand in scope or wane and need to be revitalized. In addition, the elements of coalition building may not necessarily occur in strict sequential order. Depending on the context and existing systems in place, coalitions may be able to use situational analyses that have already been conducted or utilize an existing active network. In each setting, it is important to understand the needs of the coalition and focus on the elements of this guide that align best with those needs.
Tuberculosis is one of the world’s deadliest diseases, and multi-drug resistant TB has contributed significantly to the growing global threat of antimicrobial resistance. Yet in many of the countries most burdened by the disease, about half of those who have TB see private medicine vendors before any other health care professional. That can compound the […]
Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats— one that could erode the current progress against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. In conjunction with World Antibiotic Awareness Week (14-20 November), the SIAPS Program has published a technical program update on Combating Antimicrobial Resistance with Stronger Health […]
To learn more about SIAPS program activities worldwide, please read our annual report for program year 6.
Project dates: January 2012 – September 2017
A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS, at USAID in Arlington, VA […]